EUVIMEDEUVIMED entdecken
Multizentrische Studie

Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia

Kazuya Takahashi, Hiroki Sato iD, Yuto Shimamura, Hirofumi Abe, Hironari Shiwaku, Junya Shiota, Chiaki Sato, Kenta Hamada, Masaki Ominami, Yoshitaka Hata, Hisashi Fukuda, Ryo Ogawa und 5 weitere

Journal of Gastroenterology · 2024

DOI: 10.1007/s00535-024-02119-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, 2024. Verfasst von Kazuya Takahashi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 757-1, Asahimachidori, Chuo-Ku, Niigat…. Hauptthemen laut MEDLINE: Chest Pain, Deglutition Disorders, Esophageal Achalasia, Quality of Life. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: JGA Clinical Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Symptom scales for achalasia after per-oral endoscopic myotomy (POEM) are lacking. This study aimed to propose a new scale based on the conventional Eckardt score (c-ES) and evaluate persistent symptoms that impair patients' quality of life (QOL) post-POEM. METHODS: Dysphagia, regurgitation, and chest pain frequencies were assessed using a 6-point scale modified-ES (m-ES) after POEM, with "occasional" symptoms on the c-ES further subdivided into three-period categories on m-ES. Symptom severity was further evaluated using a 5-point scale ranging from 1 to 5 points, with a score ≥ 3 points defined as persistent symptoms impairing QOL. We analyzed the correlation between the m-ES and severity score, diagnostic performance of the m-ES for persistent symptoms, and overlaps between each residual symptom. RESULTS: Overall, 536 patients (median follow-up period, 2.9 years) post-POEM were included in this multicenter study. Significant correlations were observed between the m-ES and severity scores for dysphagia (r = 0.67, p < 0.01), regurgitation (r = 0.73, p < 0.01), and chest pain (r = 0.85, p < 0.01). Twenty-six patients (4.9%) had persistent symptoms post-POEM, and 23 of them had m-ES-specific symptom frequency ≥ once a month, which was determined as the optimal frequency threshold for screening persistent symptoms. The total m-ES predicted persistent symptoms more accurately than the total c-ES (area under the curve: 0.95 vs. 0.79, p < 0.01). Furthermore, dysphagia and chest pain were the major residual symptoms post-POEM covering 91.4% of regurgitation. CONCLUSIONS: The new post-POEM scale successfully evaluated the QOL-based patient symptom severities. Our study implied the possibility of a simpler scale using residual dysphagia and chest pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chest PainDeglutition DisordersEsophageal AchalasiaQuality of LifeAdultAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesMyotomyNatural Orifice Endoscopic SurgerySeverity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

Chest painDysphagiaEckardt scoreQuality of lifeRegurgitation

Autor:innen und Institutionen

  • Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 757-1, Asahimachidori, Chuo-Ku, Niigata, Niigata, 951-8510, Japan.
  • Division of Gastroenterology & Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 757-1, Asahimachidori, Chuo-Ku, Niigata, Niigata, 951-8510, Japan. pyloki-sato@med.niigata-u.ac.jp.
  • Digestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan.
  • Department of Gastroenterology, Kobe University Hospital, Kobe, Japan.
  • Department of Gastroenterological Surgery, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
  • Department of Gastroenterology & Hepatology, Nagasaki University Hospital, Nagasaki, Japan.

ORCID-Profile: Hiroki Sato

Förderung

  • JGA Clinical Research Grant

Zitieren

APA

Takahashi, K., Sato, H., Shimamura, Y., Abe, H., Shiwaku, H., Shiota, J., Sato, C., Hamada, K., Ominami, M., Hata, Y., Fukuda, H., Ogawa, R., Nakamura, J., Tatsuta, T., Ikebuchi, Y., Terai, S., & Inoue, H. (2024). Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia. Journal of Gastroenterology. https://doi.org/10.1007/s00535-024-02119-6

Vancouver

Takahashi K, Sato H, Shimamura Y, Abe H, Shiwaku H, Shiota J, et al. Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia. Journal of Gastroenterology. 2024. doi:10.1007/s00535-024-02119-6

BibTeX
@article{Takahashi2024,
  author = {Takahashi, Kazuya and Sato, Hiroki and Shimamura, Yuto and Abe, Hirofumi and Shiwaku, Hironari and Shiota, Junya and Sato, Chiaki and Hamada, Kenta and Ominami, Masaki and Hata, Yoshitaka and Fukuda, Hisashi and Ogawa, Ryo and Nakamura, Jun and Tatsuta, Tetsuya and Ikebuchi, Yuichiro and Terai, Shuji and Inoue, Haruhiro},
  title = {Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia},
  journal = {Journal of Gastroenterology},
  year = {2024},
  doi = {10.1007/s00535-024-02119-6}
}
Kostenlos starten →